Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Cabrera-Fuentes 2016 Basic Res Cardiol

From Bioblast
Publications in the MiPMap
Cabrera-Fuentes HA, Aragones J, Bernhagen J, Boening A, Boisvert WA, Bøtker HE, Bulluck H, Cook S, Di Lisa F, Engel FB, Engelmann B, Ferrazzi F, Ferdinandy P, Fong A, Fleming I, Gnaiger E, Hernández-Reséndiz S, Kalkhoran SB, Kim MH, Lecour S, Liehn EA, Marber MS, Mayr M, Miura T, Ong SB, Peter K, Sedding D, Singh MK, Suleiman MS, Schnittler HJ, Schulz R, Shim W, Tello D, Vogel CW, Walker M, Li QO, Yellon DM, Hausenloy DJ, Preissner KT (2016) From basic mechanisms to clinical applications in heart protection, new players in cardiovascular diseases and cardiac theranostics: meeting report from the third international symposium on "New frontiers in cardiovascular research". Basic Res Cardiol 111:69.

» PMID: 27743118 Open Access

Cabrera-Fuentes HA, Aragones J, Bernhagen J, Boening A, Boisvert WA, Boetker HE, Bulluck H, Cook S, Di Lisa F, Engel FB, Engelmann B, Ferrazzi F, Ferdinandy P, Fong A, Fleming I, Gnaiger Erich, Hernandez-Resendiz S, Kalkhoran SB, Kim MH, Lecour S, Liehn EA, Marber MS, Mayr M, Miura T, Ong SB, Peter K, Sedding D, Singh MK, Suleiman MS, Schnittler HJ, Schulz R, Shim W, Tello D, Vogel CW, Walker M, Li QO, Yellon DM, Hausenloy DJ, Preissner KT (2016) Basic Res Cardiol

Abstract: In this meeting report, particularly addressing the topic of protection of the cardiovascular system from ischemia/reperfusion injury, highlights are presented that relate to conditioning strategies of the heart with respect to molecular mechanisms and outcome in patients' cohorts, the influence of co-morbidities and medications, as well as the contribution of innate immune reactions in cardioprotection. Moreover, developmental or systems biology approaches bear great potential in systematically uncovering unexpected components involved in ischemia-reperfusion injury or heart regeneration. Based on the characterization of particular platelet integrins, mitochondrial redox-linked proteins, or lipid-diol compounds in cardiovascular diseases, their targeting by newly developed theranostics and technologies opens new avenues for diagnosis and therapy of myocardial infarction to improve the patients' outcome. Keywords: Cardiomyocyte signaling pathways, Cardioprotection, Cardiovascular disease, Co-morbidities, Drug targeting, Endothelial permeability, Extracellular RNA (eRNA), Heart regeneration, Induced pluripotent stem cells, Ischemia–reperfusion injury, Lipid metabolism, MicroRNAs (miRNAs), Mitochondria, Remote ischemic conditioning

O2k-Network Lab: DK Aarhus Boetker HE, SG Singapore Hausenloy DJ


Labels: MiParea: mt-Medicine  Pathology: Cardiovascular  Stress:Ischemia-reperfusion